Jose María Teijón
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jose María Teijón has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- César Teijón
Dpto. Enfermería, Facultad de Enfermería, Fisioterapia y Podología, Ciudad Universitaria s/n, UCM, 28040 Madrid, Spain
6 shared publications - Rosa Olmo
Dpto. Bioquímica y Biología Molecular III, Facultad de Medicina, Ciudad Universitaria s/n, UCM, 28040 Madrid, Spain
6 shared publications M.V. Bernardo
Departamento de Bioquímica y Biología Molecular, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain
2 shared publicationsA. Romero
Departamento de Ingenierı́a Quı́mica, Facultad de Quı́micas, Universidad Complutense de Madrid, Spain
1 shared publicationArturo Romero
Departamento de Ingenierı́a Quı́mica, Facultad de Ciencias Quı́micas, Universidad Complutense de Madrid, 28040 Madrid, Spain
1 shared publication- Carlos Santiago Romero Magdalena
Faculty of Health Sciences, Universidad Internacional de la Rioja, Pozuelo de Alarcón, 28224 Madrid, Spain
1 shared publication
Latest Publications
- 15 September 2008
- Published by Wiley in Polymer International
- Vol. 57 (11) , 1215-1225
Preparation and characterization of nanoparticulate poly( N ‐isopropylacryl‐ amide) hydrogel for the controlled release of anti‐tumour drugs
BACKGROUND: Poly( N ‐isopropylacrylamide) (PNIPA) nanohydrogels were synthesized by inverse microemulsion to be used for the controlled release of anti‐tumour drugs. Different methods were used to obtain drug‐loaded xerogels, and their effect on drug release was studied, and evaluated using mathematical modelling. RESULTS: Nanoparticulate hydrogels, with a z ‐average diameter of 170 nm, were loaded with 5‐fluorouracil (5‐FU), methotrexate (MTX) or mitomycin C (MMC) by using spray drying (SD) and freeze drying (FD). Xerogels obtained by SD consisted of individual and independent particles, whereas particles established interactions in xerogels obtained by FD. Total drug release took place at 6 and 7 h from 5‐FU‐loaded and MMC‐loaded xerogels prepared by SD, whereas MTX was expelled from the xerogels formed using the SD process. Drug release was slower from xerogels prepared by FD: 5‐FU at 32 h, MMC at 120 h and MTX at 240 h. The Higuchi model most aptly fits the dissolution data. Non‐Fickian and Fickian release behaviour can be attributed to SD and FD formulations, respectively. CONCLUSION: The amount of drug loaded, the morphology of xerogels as well as the drug release characteristics not only depend on the drug but also mainly on the process used to obtain the drug‐loaded PNIPA xerogels. Copyright © 2008 Society of Chemical Industry
- 15 September 2008
- Published by Wiley in Polymer International
- Vol. 57 (11) , 1215-1225
Preparation and characterization of nanoparticulate poly( N ‐isopropylacryl‐ amide) hydrogel for the controlled release of anti‐tumour drugs
BACKGROUND: Poly( N ‐isopropylacrylamide) (PNIPA) nanohydrogels were synthesized by inverse microemulsion to be used for the controlled release of anti‐tumour drugs. Different methods were used to obtain drug‐loaded xerogels, and their effect on drug release was studied, and evaluated using mathematical modelling. RESULTS: Nanoparticulate hydrogels, with a z ‐average diameter of 170 nm, were loaded with 5‐fluorouracil (5‐FU), methotrexate (MTX) or mitomycin C (MMC) by using spray drying (SD) and freeze drying (FD). Xerogels obtained by SD consisted of individual and independent particles, whereas particles established interactions in xerogels obtained by FD. Total drug release took place at 6 and 7 h from 5‐FU‐loaded and MMC‐loaded xerogels prepared by SD, whereas MTX was expelled from the xerogels formed using the SD process. Drug release was slower from xerogels prepared by FD: 5‐FU at 32 h, MMC at 120 h and MTX at 240 h. The Higuchi model most aptly fits the dissolution data. Non‐Fickian and Fickian release behaviour can be attributed to SD and FD formulations, respectively. CONCLUSION: The amount of drug loaded, the morphology of xerogels as well as the drug release characteristics not only depend on the drug but also mainly on the process used to obtain the drug‐loaded PNIPA xerogels. Copyright © 2008 Society of Chemical Industry
- 25 October 2005
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 99 (12) , 2395-2402
Structural and functional implications of the hexokinase–nickel interaction
- 25 October 2005
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 99 (12) , 2395-2402
Structural and functional implications of the hexokinase–nickel interaction
- 1 September 2005
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 22 (6) , 671-682
5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: Characterization and drug release
5-Fluorouracil (5-FU), a hydrosoluble anti-neoplastic drug, was encapsulated in microspheres of poly(D,L-lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) polymers using the spray-drying technique, in order to obtain small size microspheres with a significant drug entrapment efficiency. Drug-loaded microspheres included between 47 ± 11 and 67 ± 12 µg 5-FU mg−1 microspheres and the percentage of entrapment efficiency was between 52 ± 12 and 74 ± 13. Microspheres were of small size (average diameter: 0.9 ± 0.4–1.4 ± 0.8 µm microspheres without drug; 1.1 ± 0.5–1.7 ± 0.9 µm 5-FU-loaded microspheres) and their surface was smooth and slightly porous, some hollows or deformations were observed in microspheres prepared from polymers with larger Tg. A fractionation process of the raw polymer during the formation of microspheres was observed as an increase of the average molecular weight and also of Tg of the polymer of the microspheres. The presence of 5-FU did not modify the Tg values of the microspheres. Significant interactions between the drug and each one of the polymers did not take place and total release of the included drug was observed in all cases. The time needed for the total drug release (28–129 h) was in the order PLA > PLGA 75/25 > PLGA 50/50. A burst effect (17–20%) was observed during the first hour and then a period of constant release rate (3.52 ± 0.82–1.46 ± 0.26 µg 5-FU h−1 per milligram of microspheres) up to 8 or 13 h, depending on the polymer, was obtained.
- 1 September 2005
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 22 (6) , 671-682
5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: Characterization and drug release
5-Fluorouracil (5-FU), a hydrosoluble anti-neoplastic drug, was encapsulated in microspheres of poly(D,L-lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) polymers using the spray-drying technique, in order to obtain small size microspheres with a significant drug entrapment efficiency. Drug-loaded microspheres included between 47 ± 11 and 67 ± 12 µg 5-FU mg−1 microspheres and the percentage of entrapment efficiency was between 52 ± 12 and 74 ± 13. Microspheres were of small size (average diameter: 0.9 ± 0.4–1.4 ± 0.8 µm microspheres without drug; 1.1 ± 0.5–1.7 ± 0.9 µm 5-FU-loaded microspheres) and their surface was smooth and slightly porous, some hollows or deformations were observed in microspheres prepared from polymers with larger Tg. A fractionation process of the raw polymer during the formation of microspheres was observed as an increase of the average molecular weight and also of Tg of the polymer of the microspheres. The presence of 5-FU did not modify the Tg values of the microspheres. Significant interactions between the drug and each one of the polymers did not take place and total release of the included drug was observed in all cases. The time needed for the total drug release (28–129 h) was in the order PLA > PLGA 75/25 > PLGA 50/50. A burst effect (17–20%) was observed during the first hour and then a period of constant release rate (3.52 ± 0.82–1.46 ± 0.26 µg 5-FU h−1 per milligram of microspheres) up to 8 or 13 h, depending on the polymer, was obtained.
- 1 October 2004
- Published by Wiley in Drug Development Research
- Vol. 63 (2) , 41-53
Preparation and characterization of 5‐fluorouracil‐loaded poly(ϵ‐caprolactone) microspheres for drug administration
Microspheres of 5‐fluorouracil‐loaded poly(ϵ‐caprolactone) (PCL) were prepared by spray‐drying procedure. The degradation characteristics and 5‐fluorouracil release in vitro as well as in vivo were investigated. The average molecular weight, weight loss, crystallinity, and morphology of microspheres were determined using GPC, DSC, and SEM, at different times during the in vitro degradation process. The size distribution of the microspheres indicated that most of the particles were smaller than 3 µm. A 30% weight loss as well as an increase of crystallinity were observed on day 330 of incubation. The percentage of entrapment efficiency of 5‐FU was 49% (44 µg of drug/mg of microspheres). The in vitro total release of 5‐FU took place in 8 days. Determination of plasma 5‐FU concentration in vivo using s.c. injection of 5‐FU‐loaded microspheres in Wistar rats by HPLC with analysis of data using a non‐compartmental model showed drug in plasma 18 days after administration with a maximum drug concentration of 1.5 µg/ml at 96 h. Pharmacokineticallly, a significant increase of AUC and MRT of 5‐FU with regard to the administration of the drug in solution. Scanning electron microscopy and histological studies indicated that the microspheres were surrounded by connective tissue and inflammatory processes were not evident. As a result of these characteristics, the 5‐FU‐loaded PCL microspheres could be used for drug delivery. Drug Dev Res 63:41–53, 2004.
- 1 October 2004
- Published by Wiley in Drug Development Research
- Vol. 63 (2) , 41-53
Preparation and characterization of 5‐fluorouracil‐loaded poly(ϵ‐caprolactone) microspheres for drug administration
Microspheres of 5‐fluorouracil‐loaded poly(ϵ‐caprolactone) (PCL) were prepared by spray‐drying procedure. The degradation characteristics and 5‐fluorouracil release in vitro as well as in vivo were investigated. The average molecular weight, weight loss, crystallinity, and morphology of microspheres were determined using GPC, DSC, and SEM, at different times during the in vitro degradation process. The size distribution of the microspheres indicated that most of the particles were smaller than 3 µm. A 30% weight loss as well as an increase of crystallinity were observed on day 330 of incubation. The percentage of entrapment efficiency of 5‐FU was 49% (44 µg of drug/mg of microspheres). The in vitro total release of 5‐FU took place in 8 days. Determination of plasma 5‐FU concentration in vivo using s.c. injection of 5‐FU‐loaded microspheres in Wistar rats by HPLC with analysis of data using a non‐compartmental model showed drug in plasma 18 days after administration with a maximum drug concentration of 1.5 µg/ml at 96 h. Pharmacokineticallly, a significant increase of AUC and MRT of 5‐FU with regard to the administration of the drug in solution. Scanning electron microscopy and histological studies indicated that the microspheres were surrounded by connective tissue and inflammatory processes were not evident. As a result of these characteristics, the 5‐FU‐loaded PCL microspheres could be used for drug delivery. Drug Dev Res 63:41–53, 2004.
- 30 November 2003
- Published by Elsevier in Il Farmaco
- Vol. 58 (11) , 1187-1191
Sustained release of bupivacaine from devices based on chitosan
- 30 November 2003
- Published by Elsevier in Il Farmaco
- Vol. 58 (11) , 1187-1191
Sustained release of bupivacaine from devices based on chitosan
- 14 October 2003
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 57 (2) , 225-233
Cytarabine release from comatrices of albumin microspheres in a poly(lactide–co-glycolide) film: in vitro and in vivo studies
- 14 October 2003
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 57 (2) , 225-233
Cytarabine release from comatrices of albumin microspheres in a poly(lactide–co-glycolide) film: in vitro and in vivo studies
- 30 September 2003
- Published by Elsevier in Toxicology
- Vol. 191 (2-3) , 245-258
Effects of lead administration at low doses by different routes on rat spleens. Study of response of splenic lymphocytes and tissue lysozyme
- 30 September 2003
- Published by Elsevier in Toxicology
- Vol. 191 (2-3) , 245-258
Effects of lead administration at low doses by different routes on rat spleens. Study of response of splenic lymphocytes and tissue lysozyme
- 30 January 2003
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 55 (2) , 229-236
Preparation of bupivacaine-loaded poly(ɛ-caprolactone) microspheres by spray drying: drug release studies and biocompatibility
- 30 January 2003
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 55 (2) , 229-236
Preparation of bupivacaine-loaded poly(ɛ-caprolactone) microspheres by spray drying: drug release studies and biocompatibility